Category
Biologics & Advanced Therapies
Guides to IBD biologics and advanced therapies such as Entyvio, Skyrizi, Stelara, Tremfya and Rinvoq: dosing, side effects, comparisons and access.
Tremfya vs Omvoh for Ulcerative Colitis: Which to Choose?
Tremfya vs Omvoh for ulcerative colitis: compare remission data, bowel urgency outcomes, induction routes and dosing to choose with your GI.
Tremfya vs Remicade for Crohn's: Comparing Biologics
Tremfya vs Remicade for Crohn's: compare onset, safety, IV vs SC dosing, switching and biosimilar costs to make an informed choice with your GI.
Tremfya vs Remicade for Ulcerative Colitis: Patient Guide
Tremfya vs Remicade for ulcerative colitis: compare QUASAR and ACT evidence, onset, safety, IV vs SC dosing, costs and switching with your GI.
Tremfya vs Stelara for Crohn's Disease: GALAXI Trial
Tremfya vs Stelara for Crohn's: compare GALAXI results, including 44% to 46% vs about 30% endoscopic response, safety and dosing. See who may benefit.
Tremfya vs Stelara for Ulcerative Colitis: Key Comparison
Tremfya vs Stelara for ulcerative colitis: compare week 12 efficacy, p19 vs p40 targeting, dosing, safety and cost to guide your GI visit.
Tysabri vs Cimzia for Crohn's Disease: A Patient Guide
Tysabri vs Cimzia for Crohn's: compare efficacy, PML risk, pregnancy considerations, and IV infusions vs home injections before your GI visit.
Tysabri vs Entyvio for Crohn's: Comparing Integrin Biologics
Tysabri vs Entyvio for Crohn's: compare PML risk, TOUCH rules, and 4- vs 8-week maintenance dosing, then prepare key questions for your GI.
Tysabri vs Humira for Crohn's Disease: A Comparison
Tysabri vs Humira for Crohn's: compare efficacy, PML risk, TOUCH monitoring, home injections and IV infusions to discuss your options with your GI.
Tysabri vs Omvoh for Crohn's Disease: A Comparison
Tysabri vs Omvoh for Crohn's: compare efficacy, PML risk, TOUCH restrictions, and IV vs at-home dosing to prepare for a treatment talk with your GI.
Tysabri vs Remicade for Crohn's Disease: Key Differences
Compare Tysabri and Remicade for Crohn's by efficacy, PML risk, TOUCH access, infusion schedules and dose flexibility to prepare for your GI visit.
Tysabri vs Skyrizi for Crohn's Disease: Which to Choose?
Tysabri vs Skyrizi for Crohn's: compare efficacy, PML risk, TOUCH restrictions and dosing to prepare for a shared decision with your GI.
Tysabri vs Stelara for Crohn's Disease: How They Compare
Tysabri vs Stelara for Crohn’s: compare efficacy, safety, dosing, PML risk and TOUCH restrictions, and learn why Stelara is usually tried first.
Tysabri vs Tremfya for Crohn's Disease: Key Differences
Tysabri vs Tremfya for Crohn's: compare efficacy, PML risk, TOUCH restrictions, and IV vs at-home dosing so you can discuss options with your GI.
What to Ask Before Switching to an IBD Biosimilar
Switching to an IBD biosimilar? Use this question checklist to confirm why, dosing, monitoring, interchangeability, and your baseline with your GI.
What to Do When an IBD Infusion or Injection Is Delayed
IBD infusion or injection delayed? Learn who to call first, what to document, why a few days differ from months, and how to prevent repeat gaps.
When a Biologic Worked and Then Stopped: A Guide to Secondary Loss of Response
Has your IBD biologic stopped working? Learn how inflammation tests, trough levels and antibody results guide dose escalation, added therapy or switching.
When Your Crohn's Biologic Stops Working: Next Steps
Crohn's biologic stopped working? Learn how drug levels and antibody tests guide dose changes or switches, and what symptom data to bring your GI.
When Your UC Biologic Stops Working: Next Steps
UC biologic stopped working? Learn how therapeutic drug monitoring guides dose escalation, switching, oral options, and questions for your GI.